After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
DAWN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Day One Biopharmaceuticals Inc is $754.07M. A total of 0.9 million shares were traded on the day, compared to an average of 1.17M shares.
In the most recent transaction, York Charles N II sold 4,370 shares of DAWN for 11.96 per share on Feb 18 ’25. After the transaction, the COO, CFO AND SECRETARY now owns 252,638 company shares. In a previous transaction on Feb 18 ’25, Dubow Adam sold 4,646 shares at 11.96 per share. DAWN shares that GENERAL COUNSEL owns now total 39,602.
Among the insiders who sold shares, Bender Jeremy disposed of 12,048 shares on Feb 18 ’25 at a per-share price of $11.96. This resulted in the CHIEF EXECUTIVE OFFICER holding 128,015 shares of DAWN after the transaction. In another insider transaction, ADAM DUBOW bought 4,646 shares at $11.96 per share on Feb 18 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, DAWN has a high of $18.07 and a low of $6.41.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $4.97, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DAWN is Buy with a score of 4.67.
